Bank of America Corp DE lessened its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 3.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 151,242 shares of the company's stock after selling 5,369 shares during the period. Bank of America Corp DE owned 1.00% of U.S. Physical Therapy worth $13,417,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of USPH. CBIZ Investment Advisory Services LLC lifted its position in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after buying an additional 122 shares in the last quarter. Venturi Wealth Management LLC raised its stake in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares during the period. Pacer Advisors Inc. purchased a new position in U.S. Physical Therapy during the fourth quarter valued at approximately $113,000. Aquatic Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 18.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after purchasing an additional 198 shares during the period. Finally, Mutual of America Capital Management LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter worth $203,000.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on USPH shares. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JPMorgan Chase & Co. decreased their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. JMP Securities reissued a "market outperform" rating and set a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Barrington Research lowered their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $109.00.
Read Our Latest Analysis on U.S. Physical Therapy
Insider Transactions at U.S. Physical Therapy
In other news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company's stock.
U.S. Physical Therapy Stock Down 2.6%
Shares of USPH opened at $77.36 on Thursday. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of 82.30, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $105.80. The business's 50 day simple moving average is $71.96 and its 200-day simple moving average is $83.49. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. U.S. Physical Therapy's quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.51 earnings per share. As a group, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be issued a $0.45 dividend. The ex-dividend date is Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.33%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.
U.S. Physical Therapy Company Profile
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.